Ace Therapeutics specializes in providing comprehensive preclinical research services and cutting-edge drug development solutions.
At Ace Therapeutics, we conduct preclinical studies using advanced disease models to evaluate potential drug candidates for efficacy and safety. Our comprehensive services cover the entire preclinical drug development process.
Leveraging our expertise in microbiology, immunology, and molecular biology, we provide guidance throughout the entire vaccine development process.
We conduct fundamental research on physiological processes in gastrointestinal and liver diseases, cell signaling pathways, tissue responses, and organ function using a variety of techniques and models.
At Ace Therapeutics, we understand the unique challenges associated with developing novel candidate drugs for gastrointestinal diseases. We offer customized preclinical services to support your research and development needs, including the development and validation of disease models, in vitro pharmacodynamic platforms, and in vivo efficacy and safety studies.
Disease types: GRED, Gastric ulcer, gastritis, appendicitis, Crohn disease, IBD, IBS
Discover MoreWith our specialized focus on hepatology, Ace Therapeutics offers a wide range of comprehensive solutions to support your research and development needs in this field. Our team of experts is dedicated to helping clients conduct in-depth disease mechanism research, drug development, diagnostic technology development, and more.
Disease types: NALDs, ALDs, hepatitis, fatty liver, liver fibrosis, liver failure, pancreatitis, pancreatic microcirculation disorder, cholecystitis, cholangitis, biliary atresia, gallstone
Discover More